Barr IG, et al. Immunology and Cell Biology. 1996; 74: 8-25.* |
Gaugler B, et al. J Exp Med. Mar. 1, 1994; 179 (3): 921-30.* |
Livingston, PO, 1995, Immunological Reviews, vol. 145, pp. 146-166.* |
Osband, Me and Susan Ross, 1990, Immunology Today, vol. 11 (6), 193-195.* |
Bocchia M, et al. Haematologica 2000; 85: 1172-1206.* |
Bengtsson K, et al. Vaccine Jun. 1996; 14 (8): 753-760.* |
Ritter G, et al. Int J Cancer 1995; 62: 668-672.* |
Cox J, et al. BioDrugs Dec. 1999; 12 (6): 439-453.* |
Ezzel C. J NIH Res Jan. 1995; 7: 46-49.* |
Mukherji B, et al. Proc. Natl Acad Sci USA Aug. 1995; 92: 8078-8082.* |
Jaeger E, et al. Int J Cancer 1996; 66: 162-169.* |
Boon T. Adv Cancer Res 1992; 58: 177-210.* |
Arceci RJ. J Mol Med 1998; 76: 80-93.* |
Lee K-H, et al. J Immunol 1999; 163: 6292-6300.* |
Zaks TZ, et al. Cancer Res Nov. 1, 1998; 58: 4902-4908.* |
Gura T. Science Nov. 7, 1997; 278: 1041-1042.* |
Bodey B, et al. Anticancer Res 2000; 20: 2665-2676.* |
Yamshchikov G, et al. Clin Cancer Res Mar. 2001; 7 (Suppl): 909s-916s.* |
Spitler LE. Cancer Biother 1995; 10 (1): 1-3.* |
Cox AL, et al. Science Apr. 29, 1994; 264: 716-719.* |
Hu X, et al. Cancer Res Jun. 1, 1996; 56: 2479-2483.* |
Gao P, et al. J Immunother 2000; 23 (6): 643-653.* |
Cox et al., “animal parasite control utilizing biotechnology”, Adv. Adj. Tech. and App., 4:49-112, 1992. |
Helling et al, “Ganglioside conjugate vaccines” Mol. Chem. Nuero., vol. 21, 21:299-309, 1994. |
Sen et al., “prelinical evaluation in nonhuman primates of murine monoclonal anti-idiotype that mimics the Disialoganglioside GD21”, Clinical Cancer Resrch, 3:1969-1976, 1997. |